News
Sanofi agreed to buy Blueprint Medicines for up to $9.5 billion, the French drugmaker’s biggest move yet to replenish its drug pipeline since it sold a controlling stake in its consumer ...
Hosted on MSN1mon
Sanofi to Buy Immunology Biotech Blueprint for $9.1 Billion - MSNSanofi agreed to buy Blueprint Medicines Corp. for at least $9.1 billion as the French drugmaker expands further in rare immunological diseases.
Because of Biosphere 2, we now know what not to do on Mars and elsewhere. Don’t mix your farm area with your living space; keep it in a separate dome. Don’t rely on plants to supply all your ...
Biosphere 2 is operated by the University of Arizona and remains a key hub for climate research. Tours are available every day from 9 a.m. - 4 p.m. with adult tickets starting at $29. Check it out ...
Researchers who study Earth's biosphere tend to operate from one of three scientific cultures, each with distinct ways of conducting science, and which have been operating mostly independently ...
Biosphere zaps germs with UV light to make biomanufacturing cheaper. Tim De Chant. 5:00 AM PST · January 9, 2025. Ask any scientist that has worked with cell cultures in a lab: Contamination is ...
It's a living, breathing laboratory called Biosphere 2. Researchers created the facility in the late '80s and early '90s to see if humans could survive in an artificial, self-sustaining ecosystem.
Sanofi agreed to buy Blueprint Medicines Corp. for at least $9.1 billion as the French drugmaker expands further in rare immunological diseases. Sanofi will pay $129 per share in cash for the US ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results